Cancer trials: Search results
Results: 151 items found. Showing page 4 of 6.
Refine results
COV-IMMUNO - A RANDOMIZED, PHASE III TRIAL OF IMMUNIZATION WITH IMM-101 VERSUS OBSERVATION FOR THE PREVENTION OF SEVERE RESPIRATORY AND COVID-19RELATED INFECTIONS IN CANCER PATIENTS AT INCREASED RISK OF EXPOSURE (IC.8)
Trial short name: IC.8
Cancer type:
Cancer location:
Disease stage: Early and Advanced Cancer
Trial phase: Phase 3
Immune response dynamics in Gleason 9-10 patients undergoing radiotherapy: A proof of principle study
Trial short name: ICIC
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Advanced Cancer
Trial phase: Other
A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or Chemotherapy or TransCon TLR7/8 Agonist in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies (IL Believe)
Trial short name: IL Believe
Cancer type: Melanoma
Cancer location: Melanoma
Disease stage: Early Cancer
Trial phase: Phase 1, Phase 2
A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma
Trial short name: IMbrave152
Cancer type: Gastrointestinal
Cancer location: Gastrointestinal
Disease stage: Early Cancer
Trial phase: Phase 3
A Phase III, Double-Blind, Multicenter, Randomized Study of Atezolizumab (Anti-PDL1 Antibody) Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy
Trial short name: IMVIGOR11
Cancer type: Genitourinary
Cancer location: Bladder
Disease stage: Early Cancer
Trial phase: Phase 3
MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer: A Multi-centre Prospective Cohort Study
Trial short name: INSIGHT
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Other
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma
Trial short name: Keynote-689
Cancer type: Head & Neck
Cancer location: Head & Neck
Disease stage: Early Cancer
Trial phase: Phase 3
Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)
Trial short name: KEYNOTE-826
Cancer type: Gynecology
Cancer location: Gynecology
Disease stage: Early Cancer
Trial phase: Phase 3
A Randomized, Double-blind, Placebo-controlled Phase 3 Trial of Pembrolizumab (MK-3475) Versus Placebo in Participants with Esophageal Carcinoma Receiving Concurrent Definitive Chemoradiotherapy (KEYNOTE 975)
Trial short name: Keynote-975
Cancer type: Lung
Cancer location: Lung
Disease stage: Early Cancer
Trial phase:
A Phase 3, Randomized, Double-Blind Study of Pembrolizumab Versus Placebo in Combination With Paclitaxel With or Without Bevacizumab for the Treatment of Platinum-resistant Recurrent Ovarian Cancer (KEYNOTE-B96/ENGOT-ov65)
Trial short name: Keynote-B96
Cancer type: Gynecology
Cancer location: Gynecology
Disease stage: Early Cancer
Trial phase: Phase 3
Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-365)
Trial short name: KN365 Prostate
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase: Phase 1, Phase 2
A phase 3 trial of fianlimab (REGN3767, Anti-Lag3) + cemiplimab versus pembrolizumab in patients with previously untreated unresectable locally advanced or metastatic melanoma
Trial short name: LAG3 REGN MEL
Cancer type: Melanoma
Cancer location: Melanoma
Disease stage: Early Cancer
Trial phase: Phase 3
Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy
Trial short name: LEAP-009
Cancer type: Head & Neck
Cancer location: Head & Neck
Disease stage: Early Cancer
Trial phase: Phase 2
A Phase 3, Open-label, Randomized, Prospective Study of Apalutamide with Continued Versus Intermittent Androgen-Deprivation Therapy (ADT) following PSA Response in Participants with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Trial short name: LIBERTAS
Cancer type: Genitourinary
Cancer location: Genitourinary
Disease stage: Early Cancer
Trial phase: Phase 3
A Phase II Study of Olaparib Monotherapy in Participants with Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer
Trial short name: Lynk-002 (MK7339-002)
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 2
The Effect of Megestrol Acetate on Grade 2 Endometrioid Endometrial Cancer in Patients Waiting for Definitive Surgery, a Prospective Trial
Trial short name: MA-EEC
Cancer type: Gynecology
Cancer location: Gynecology
Disease stage: Early Cancer
Trial phase:
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial
Trial short name: MAC.27 COMPASSHER2
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 3
NRG-BR007: A PHASE III CLINICAL TRIAL EVALUATING DE-ESCALATION OF BREAST RADIATION FOR CONSERVATIVE TREATMENT OF STAGE I, HORMONE SENSITIVE, HER2-NEGATIVE, ONCOTYPE RECURRENCE SCORE ≤ 18 BREAST CANCER
Trial short name: MAC.28 (DEBRA)
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 3
Management of National MDS Clinical Database and Local Tissue Bank
Trial short name: MDS Database
Cancer type: Blood Related
Cancer location: Myelodysplastic Syndromes
Disease stage: Other
Trial phase: Other
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma (MelMarT-II)
Trial short name: ME.15
Cancer type: Melanoma
Cancer location: Melanoma
Disease stage: Early Cancer
Trial phase: Phase 3
A randomized phase II trial of adjuvant melanoma with or without cabozantinib in patients with resected mucosal melanoma.
Trial short name: MEC.6
Cancer type: Melanoma
Cancer location: Melanoma
Disease stage: Early Cancer
Trial phase: Phase 2
Molecular, Imaging, and Neurological assessment Database for CNS tumours
Trial short name: MIND-CNS
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Other
A Phase 1/2 Randomized, Umbrella Study to Evaluate the Safety and Efficacy of Pembrolizumab Plus Enfortumab Vedotin (EV) in Combination With Investigational Agents Versus Pembrolizumab Plus EV, as First-Line Treatment for Participants With Advanced Urothelial Carcinoma (KEYMAKER-U04): Substudy 04B
Trial short name: MK-3475-04B
Cancer type: Genitourinary
Cancer location: Genitourinary
Disease stage: Early Cancer
Trial phase: Phase 1, Phase 2
An Open-label, Randomized, Phase 3 Study of MK-6482 in Combination With Lenvatinib (MK-7902) vs Cabozantinib in Participants With Advanced Renal Cell Carcinoma Who Have Progressed After Prior Anti-PD-1/L1 Therapy
Trial short name: MK-6482-011
Cancer type: Genitourinary
Cancer location: Kidney
Disease stage: Early Cancer
Trial phase: Phase 3
An Open-label, Randomized Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or MK-1308A in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, as First-Line Treatment in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
Trial short name: MK-6482-012
Cancer type: Genitourinary
Cancer location: Kidney
Disease stage: Early Cancer
Trial phase: Phase 3
